In order to assess the role of FANCF, FANCL, and FANCD2 in the sensitivity of lung cancer cells to cisplatin, we designed three different siRNA sequences (siRNA-1, siRNA-2, siRNA-3) for each gene to knockdown the three genes respectively in A549 cells. This evidence concerns the gene FANCF and lung cancer.